Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-009376
Filing Date
2025-04-01
Accepted
2025-04-01 16:35:16
Documents
1
Period of Report
2025-03-28

Document Format Files

Seq Description Document Type Size
1 form4-04012025_080413.html 4  
1 form4-04012025_080413.xml 4 6150
  Complete submission text file 0001415889-25-009376.txt   7587
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VENTYX BIOSCIENCES, INC. 332 ENCINITAS BLVD. SUITE 200 ENCINITAS CA 92024
Business Address
Nuss John (Reporting) CIK: 0001874108 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 25800310